123 related articles for article (PubMed ID: 9627059)
1. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo.
Asano M; Yukita A; Matsumoto T; Hanatani M; Suzuki H
Hybridoma; 1998 Apr; 17(2):185-90. PubMed ID: 9627059
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121).
Asano M; Yukita A; Matsumoto T; Matsuo K; Kondo S; Suzuki H
Hybridoma; 1995 Oct; 14(5):475-80. PubMed ID: 8575796
[TBL] [Abstract][Full Text] [Related]
4. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
Asano M; Yukita A; Suzuki H
Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571
[TBL] [Abstract][Full Text] [Related]
5. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
Kim KJ; Li B; Houck K; Winer J; Ferrara N
Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice.
Kanai T; Konno H; Tanaka T; Baba M; Matsumoto K; Nakamura S; Yukita A; Asano M; Suzuki H; Baba S
Int J Cancer; 1998 Sep; 77(6):933-6. PubMed ID: 9714067
[TBL] [Abstract][Full Text] [Related]
9. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.
Bauer AJ; Terrell R; Doniparthi NK; Patel A; Tuttle RM; Saji M; Ringel MD; Francis GL
Thyroid; 2002 Nov; 12(11):953-61. PubMed ID: 12490072
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.
Yukita A; Asano M; Okamoto T; Mizutani S; Suzuki H
Anticancer Res; 2000; 20(1A):155-60. PubMed ID: 10769648
[TBL] [Abstract][Full Text] [Related]
12. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
13. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Perrotte P; Matsumoto T; Inoue K; Kuniyasu H; Eve BY; Hicklin DJ; Radinsky R; Dinney CP
Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
[TBL] [Abstract][Full Text] [Related]
15. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
Presta LG; Chen H; O'Connor SJ; Chisholm V; Meng YG; Krummen L; Winkler M; Ferrara N
Cancer Res; 1997 Oct; 57(20):4593-9. PubMed ID: 9377574
[TBL] [Abstract][Full Text] [Related]
16. VEGF-Trap: a VEGF blocker with potent antitumor effects.
Holash J; Davis S; Papadopoulos N; Croll SD; Ho L; Russell M; Boland P; Leidich R; Hylton D; Burova E; Ioffe E; Huang T; Radziejewski C; Bailey K; Fandl JP; Daly T; Wiegand SJ; Yancopoulos GD; Rudge JS
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11393-8. PubMed ID: 12177445
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies.
Jayson GC; Zweit J; Jackson A; Mulatero C; Julyan P; Ranson M; Broughton L; Wagstaff J; Hakannson L; Groenewegen G; Bailey J; Smith N; Hastings D; Lawrance J; Haroon H; Ward T; McGown AT; Tang M; Levitt D; Marreaud S; Lehmann FF; Herold M; Zwierzina H;
J Natl Cancer Inst; 2002 Oct; 94(19):1484-93. PubMed ID: 12359857
[TBL] [Abstract][Full Text] [Related]
18. Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin.
Borgström P; Gold DP; Hillan KJ; Ferrara N
Anticancer Res; 1999; 19(5B):4203-14. PubMed ID: 10628376
[TBL] [Abstract][Full Text] [Related]
19. [The effect of antibody against vascular endothelial growth factor on tumor growth].
Wang G; Wang N; Liu T
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):163-6. PubMed ID: 10920886
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new potent, in vivo neutralizing monoclonal antibody to human vascular endothelial growth factor.
Schlaeppi JM; Siemeister G; Weindel K; Schnell C; Wood J
J Cancer Res Clin Oncol; 1999; 125(6):336-42. PubMed ID: 10363565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]